Navigation Links
Linkwell Corporation Selected to Train and License all Disinfectant and Pest Control Professionals in China and for the Beijing Olympics
Date:4/11/2008

SHANGHAI, China, April 11 /Xinhua-PRNewswire-FirstCall/ -- Linkwell Corporation (Linkwell) (OTC Bulletin Board: LWLL), a leading developer, manufacturer and distributor of healthcare related disinfectants in China, announced today that its wholly owned subsidiary Shanghai LiKang Disinfection Hi-Tech Company, Ltd., (LiKang Disinfectant) was selected by the Chinese Ministry of Health (MOH) and Ministry of Human Resources and Social Security (MOHRSS) to implement China's new disinfection vocational training and licensing program. The MOH and MOL created the program to improve China's public health safety security by standardizing the disinfectant industry's qualification and licensing standards.

Recently, the Vocational Ability Authentication Centers, a division of MOH sponsored an initiatives seminar of leading industry experts, to develop and implement a national training and licensing program for the disinfectant industry. Leading this effort were Mr. Liubo Zhang, the Chairman of the Office of Infection Control (a division of the Chinese Center for Disease Control and Prevention); Mr. Hualin Yang, the Secretary-General of the China Pest Infestation Control and Sanitation Association (a division of China's Ministry of Agriculture); Mr. Xuelian Bian, the Vice Director of the Shanghai Disinfection Association, and Chairman & CEO of Linkwell; and experts from the esteemed Beijing Xiehe and Shanghai Ruijin Hospitals.

These industry experts adapted LiKang Disinfectant's education program and recommended that it become China's official program. The Chairmen of MOH and MOHRSS accepted the experts' recommendation for standardized national vocational training and licensing program, and signed exclusive agreements with LiKang Disinfectant to implement and manage the program. In coordination with the China Pest Infestation Control and Sanitation Association, LiKang Disinfectant will initiate the first training class for the disinfection and pest control professionals supporting the 2008 Beijing Olympics.

"This national training and licensing program will provide essential health services for the Beijing Olympics and all of China," commented Xuelian Bian, "being selected to implement and manage this monumental program is an honor for LiKang Disinfectant and provides several new business opportunities." In addition to direct compensation for the training, LiKang Disinfectant's management believes the increase in prestige, and brand recognition will help sales of their disinfectant products.

Linkwell estimates there are one million disinfectant and pest control professionals who need this training and licensing. Management also believes they are well positioned to benefit from this program as these professionals commence the mandatory training and licensing, which will be conducted exclusively by LiKang Disinfectant's experts, using LiKang Disinfectant's products.

About Linkwell Corporation

Linkwell develops, manufactures and distributes disinfectant healthcare products in China through its subsidiary LiKang Disinfectant. Linkwell's disinfectant healthcare products are a nationally recognized domestic Chinese brand in this market segment. Linkwell products include disinfectants in liquid, tablet, powder and aerosol form. Through LiKang Disinfectant, Linkwell has a national marketing and sales presence throughout all 22 provinces, 5 autonomous regions, and 4 special municipalities of China. For more information, please visit http://www.lwll.us/ .

Safe Harbor Statement

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations or beliefs, including, but not limited to, statements concerning Linkwell's operations, financial performance and condition. For this purpose, statements that are not statements of historical fact may be deemed to be forward-looking statements. Linkwell cautions that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, but not limited to, the impact of competitive products, pricing and new technology; changes in consumer preferences and tastes; effectiveness of marketing; changes in laws and regulations; fluctuations in costs of production; and other factors as those discussed in Linkwell's reports filed with the Securities and Exchange Commission from time to time. In addition, Linkwell disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, please contact:

Investor Relations

Craig Bird

Segue Ventures LLC

Tel: +1-215-885-4981

Email: chbird@segue.biz


'/>"/>
SOURCE Linkwell Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Linkwell Chairman & CEO Addresses the Association of Chinese Nosocomial Infections Professional Committee
2. Linkwell Corporations Skin Disinfectant Product Chosen for 2008 Beijing Olympic Games
3. Shanghai Disinfection Association and Linkwell Corporation Co-Establish the Shanghai Disinfection Association Laboratory Center
4. Linkwell Corp to File to Extend Filing Date for 2007 Form 10-K
5. Linkwell Corporation Year-End 2007 Earnings Release and Conference Call Notice
6. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
7. Brooke Franchise Corporation Announces Selected July Results
8. MedThink Communications Retained by NanoBio Corporation
9. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
10. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
11. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... a new partnership with the Rhode Island Consortium for Autism Research and Treatment ... opportunity for children with autism spectrum disorder (ASD) to see films in an ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... ... February 22, 2017 , ... When ... new healthcare contact center in Georgia, PENETRON Specialty Products (PSP) provided the solution. ... healthcare systems recently invested $51 million to purchase and renovate the 185,000 square-foot ...
(Date:2/22/2017)... Angeles, CA (PRWEB) , ... February 22, 2017 , ... ... detox treatment to the thousands of individuals who have recently fallen victim to America’s ... hospital in Orange County, California, where they are free from the shame, stigma, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... leads to fewer trips the emergency room, fewer hospital admissions, and better blood ... of Managed Care® (AJMC®) finds. The study can be found here . ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017   SeraCare Life ... global in vitro diagnostics manufacturers and clinical laboratories, ... "Catalyzing Implementation of NGS-Based Tests" to be hosted ... 2017 at 11am Eastern Standard Time (US). ... highlight the need for improved performance and global ...
(Date:2/23/2017)... -- ML Capital Group, Inc. (USOTC: MLCG) today announced ... , a Colorado -based cannabis tourism company. ... (USOTC: PURA) to enter Colorado,s $19 billion ... Tours acquisition announced today is intended to accelerate MLCG,s ... ...
(Date:2/23/2017)... DIEGO , Feb. 23, 2017 ... a clinical-stage oncology drug development company, announces that ... and Drug Administration (FDA) authorizing the initiation a ... therapeutic treatment for pancreatic cancer. MVT-1075 ( 177 ... radioimmunotherapy (RIT). MabVax plans to initiate the phase ...
Breaking Medicine Technology: